Workflow
Agree Realty(ADC)
icon
Search documents
2 Incredibly Cheap High-Yield Dividend Growth Stocks to Buy Now
The Motley Fool· 2024-07-17 09:45
These two dividend growth stocks offer you at least double what you get from the S&P 500, all backed by very boring businesses.The problem with dividend growth stocks is that investors often afford them a premium valuation. Given the dividend yield equation, that basically translates to a lower yield. However, the stock market is near all-time highs right now, so the yield on the S&P 500 is disappointingly hovering at a little less than 1.3%. You can do much better than that with dividend growers like Agree ...
If You Can Only Buy One REIT Stock in July, It Better Be One Of These 3 Names
Investor Place· 2024-07-16 10:22
Real Estate Investment Trusts, or REITs, are an asset class allowing investors to gain real estate exposure without buying properties. Investors could be interested in REITs for many reasons, but the most likely one is elevated dividend yields. Not only do most REITs have higher yields than the S&P 500, but they also regularly outperform the market. Furthermore, REIT stocks are less vulnerable to significant market corrections than other stocks since they hold onto tangible assets (real estate properties). ...
The REIT Rally Has Started: 2 Picks That Still Offer Double-Digit Upside
Seeking Alpha· 2024-07-15 12:00
BernardaSv Introduction With the CPI report that came out recently, the market seems to be enthusiastic about rate cuts coming soon. When I looked at my portfolio and saw all my REIT positions up nicely, I knew the report must have been good in the eyes of investors. However, I think REITs will see further upside once the rate cuts actually happen. Let's be honest, even though we all assume rate cuts are happening this year, no one knows for sure. Anything can occur between now and then, but there are s ...
3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade
The Motley Fool· 2024-07-15 09:44
These three stocks boast an average yield that is more than three times the average dividend payer in the benchmark S&P 500 index.The market's been on a bull run, but most of the gains have been confined to a handful of tech stocks at the top. There are still plenty of high-yield dividend stocks that haven't gained as much attention as they probably deserve.Investors looking for near-certain ways to grow the stream of passive income their retirement accounts produce have some terrific options. Medtronic (MD ...
High-Yield Agree Realty: Buy, Sell, or Hold?
The Motley Fool· 2024-07-15 09:00
Agree Realty is a large net lease REIT with a strong history of dividend growth. But it might not be the best option for all income investors.On an absolute basis, Agree Realty's (ADC 0.63%) 4.7% dividend yield is very attractive when you compare it to the broader market's miserly 1.3% or so. It's even a bit higher than the average real estate investment trust (REIT) yield of nearly 4.3%.But don't make a final call about this net lease REIT just yet (net leases require tenants to pay most property-level ope ...
What is the Dividend Payout for Agree Realty Stock?
The Motley Fool· 2024-07-10 15:33
Income seekers should agree that Agree Realty is the right REIT in which to entrust one's investable capital.Some real estate investment trusts (REITs) are generous dividend payers, and Agree Realty (ADC 0.70%) certainly fits this description. However, with a little digging, you may discover an off-putting irregularity in Agree Realty's prior payout pattern.This need not be a deal breaker, though. Considering the context of Agree Realty's past payment pullback should help restore confidence in this recent d ...
REITs: Return On Equity And Cost Of Capital
Seeking Alpha· 2024-07-10 10:30
Wolterk Every real estate investor, including REITs, must assess and choose among potential investments. These choices ideally should consider not only price but also desired property type, cash earnings, earnings growth, and risks. The choice of investments also should reflect the source and cost of the funds used. It is one thing to buy a property with cash on hand. It is something else to take on debt to raise some or all of the cash. More complexity is added if you sell part of your real-estate comp ...
3 High-Yield REITs to Buy for Steady Income in a Volatile Market
Investor Place· 2024-07-08 18:38
Betting on high-yield REIT investments can prove remarkably lucrative over time. These businesses stand out in the investment world because they are obligated to return 90% of their taxable income to shareholders in the form of dividends. Additionally, REITs benefit from the exemption of corporate taxes.Of late, REITS have performed remarkably well, despite fluctuating interest rates. These REITs have proven remarkably resilient, consistently distributing sizeable dividends despite the headwinds. Hence, the ...
3 REIT Stocks That Are Screaming Buys in July
The Motley Fool· 2024-07-08 09:30
Higher interest rates have some blue chip REITs sitting on the bargain shelf.Real estate investment trusts, or REITs, are a great way for investors to add real estate exposure to their portfolios without actually buying property. These companies specialize in real estate and pay big dividends, but can be easily bought and sold like any other stock.Many REIT stocks have struggled due to higher interest rates. These companies borrow to fund growth, and higher rates make that harder (more expensive). This has ...
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
GlobeNewswire News Room· 2024-07-08 06:00
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova PartnersFunds will be used to build out Myricx Bio’s proprietary N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform and advance its pipeline of NMTi-ADCs through clinical proof of concept targeting clinically validated tumou ...